108 related articles for article (PubMed ID: 8231237)
1. Cyclophosphamide treatment of an SJL murine B-cell lymphoma increases the proportion of suppressive CD8+ over tumor-stimulatory CD4+ T-lymphocytes.
Wrone-Smith T; Cankovic M; VanBuren E; Lerman S
Leuk Res; 1993 Nov; 17(11):967-75. PubMed ID: 8231237
[TBL] [Abstract][Full Text] [Related]
2. The CD4 cell dependency of SJL/J B-cell lymphomas as a target for cyclophosphamide therapy.
Thrush GR; Placey JL; Valeriote FA; Lerman SP
Cancer Commun; 1989; 1(5):301-10. PubMed ID: 2518399
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-12-induced cytotoxicity against syngeneic B cell lymphomas of SJL/J mice.
Wajchman J; Simmons WJ; Klein A; Koneru M; Ponzio NM
Leuk Res; 2002 Jun; 26(6):577-90. PubMed ID: 12007506
[TBL] [Abstract][Full Text] [Related]
5. CD8 suppressor cell activity and its effect on CD4 helper cell-dependent growth of SJL/J B-cell lymphomas.
Thrush GR; Butch AW; Lerman SP
Cell Immunol; 1989 Sep; 122(2):555-62. PubMed ID: 2569938
[TBL] [Abstract][Full Text] [Related]
6. I-E expression does not by itself influence growth of or T cell unresponsiveness to SJL lymphomas.
Tsiagbe VK; Rabinowitz JL; Thorbecke GJ
Cell Immunol; 1991 Sep; 136(2):329-39. PubMed ID: 1831403
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of a single dose of cyclophosphamide on T cell subsets of the thymus and spleen in mice: flow cytofluorometry analysis.
Miyauchi A; Hiramine C; Tanaka S; Hojo K
Tohoku J Exp Med; 1990 Oct; 162(2):147-67. PubMed ID: 2129070
[TBL] [Abstract][Full Text] [Related]
8. Syngeneic response to SJL follicular center B cell lymphoma (reticular cell sarcoma) cells is primarily in V beta 16+ CD4+ T cells.
Tsiagbe VK; Asakawa J; Miranda A; Sutherland RM; Paterson Y; Thorbecke GJ
J Immunol; 1993 Jun; 150(12):5519-28. PubMed ID: 8099938
[TBL] [Abstract][Full Text] [Related]
9. The SJL/J T cell response to both spontaneous and transplantable syngeneic reticulum cell sarcoma is mediated predominantly by the V beta 17a+ T cell clonotype.
Katz JD; Ohnishi K; Lebow LT; Bonavida B
J Exp Med; 1988 Nov; 168(5):1553-62. PubMed ID: 2460577
[TBL] [Abstract][Full Text] [Related]
10. Modulation of antitumor immunity of tumor-bearing mice with low-dose cyclophosphamide.
Tzai TS; Lin JS; Chow NH
J Surg Res; 1996 Oct; 65(2):139-44. PubMed ID: 8903460
[TBL] [Abstract][Full Text] [Related]
11. Effects of cyclophosphamide treatment on the in vitro activity of mouse lymphoid cells after nonspecific and specific stimulation.
Snippe H; Davidse RP; Belder M; Willers JM
Int Arch Allergy Appl Immunol; 1976; 50(5):536-47. PubMed ID: 1083834
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells.
Turtle CJ; Hanafi LA; Berger C; Hudecek M; Pender B; Robinson E; Hawkins R; Chaney C; Cherian S; Chen X; Soma L; Wood B; Li D; Heimfeld S; Riddell SR; Maloney DG
Sci Transl Med; 2016 Sep; 8(355):355ra116. PubMed ID: 27605551
[TBL] [Abstract][Full Text] [Related]
13. Regulation of B-cell lymphoma growth in syngeneic SJL/J mice. establishment of tumor dormancy following administration of anti-CD4 monoclonal antibody into tumor-bearing mice.
Ohnishi K; Bonavida B
Leukemia; 1993 Nov; 7(11):1801-6. PubMed ID: 8231249
[TBL] [Abstract][Full Text] [Related]
14. B cell lymphomas of C57L/J mice; the role of natural killer cells and T helper cells in lymphoma development and growth.
Erianne1 GS; Wajchman2 J; Yauch3 R; Tsiagbe VK; Kim BS; Ponzio NM
Leuk Res; 2000 Aug; 24(8):705-18. PubMed ID: 10936423
[TBL] [Abstract][Full Text] [Related]
15. Growth of SJL/J-derived transplantable reticulum cell sarcoma as related to its ability to induce T-cell proliferation in the host. I. Dominant negative genetic influences of other parent haplotype in F1 hybrids of SJL/J mice.
Katz IR; Lerman SP; Ponzio NM; Shreffler DC; Thorbecke GJ
J Exp Med; 1980 Feb; 151(2):347-61. PubMed ID: 6985949
[TBL] [Abstract][Full Text] [Related]
16. IL-10 production in a CD5+ B cell lymphoma arising in a CD4 monoclonal antibody-treated SJL mouse.
Lin TZ; Fernandes H; Yauch R; Ponzio NM; Raveche E
Clin Immunol Immunopathol; 1992 Oct; 65(1):10-22. PubMed ID: 1382908
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity.
Ikezawa Y; Nakazawa M; Tamura C; Takahashi K; Minami M; Ikezawa Z
J Dermatol Sci; 2005 Aug; 39(2):105-12. PubMed ID: 15899580
[TBL] [Abstract][Full Text] [Related]
18. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
Lasky JL; Ponzio NM; Thorbecke GJ
J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide-modified murine peritoneal macrophages induce CD4
Majewska-Szczepanik M; Kowalczyk P; Biała D; Marcińska K; Strzępa A; Woźniak D; Sura P; Pearson J; Wen L; Szczepanik M
Pharmacol Rep; 2018 Aug; 70(4):796-803. PubMed ID: 29957340
[TBL] [Abstract][Full Text] [Related]
20. META-controlled env-initiated transcripts encoding superantigens of murine Mtv29 and Mtv7 and their possible role in B cell lymphomagenesis.
Sen N; Simmons WJ; Thomas RM; Erianne G; Zhang DJ; Jaeggli NS; Huang C; Xiong X; Tsiagbe VK; Ponzio NM; Thorbecke GJ
J Immunol; 2001 May; 166(9):5422-9. PubMed ID: 11313379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
